This video is currently visible only to AAPM Members, Affiliates and Developing Country Educational Associates. Embargo periods are typically one year from the date the presentation was first published.
Combination I-131 Radio-Immuno-Therapy and Other New I-131 Therapies David Adam, PhD, MS Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University
Graph includes member loads and non-member loads (0 total loads). Exclude non-member? A load is defined as someone coming to this page, not necesarily that they pressed play, or watched the entire presentation.